Lifeboat Foundation

UC Davis researchers have identified new cell clusters in the amygdala that could hold keys to treating anxiety and depression.

Effective treatment for anxiety, depression, and other emotional disorders may rely on the amygdala—a part of the brain that regulates strong emotional responses, particularly fear. Until recently, understanding of this structure was limited. Now, researchers at the University of California, Davis, have identified distinct clusters of cells in the amygdala of humans and non-human primates, each with unique patterns of gene expression. This discovery could pave the way for more targeted treatments for conditions like anxiety, which impact tens of millions worldwide.

The findings were published on October 30 in the American Journal of Psychiatry.

A collaborative study by researchers from Baylor College of Medicine and Illumina has showcased the exceptional capabilities of the DRAGEN (Dynamic Read Analysis for GENomics) platform in comprehensive genome analysis.

A new hydrogel semiconductor from the University of Chicago offers a groundbreaking solution for bioelectronics, blending tissue-like properties with high electronic functionality, enhancing medical device integration and effectiveness.

The perfect material for interfacing electronics with living tissue is soft, stretchable, and as water-loving as the tissue itself, making hydrogels an ideal choice. In contrast, semiconductors, the key materials for bioelectronics such as pacemakers, biosensors, and drug delivery devices, are rigid, brittle, and hydrophobic, making them impossible to dissolve in the way hydrogels have traditionally been built.

Continue reading “Revolutionary Bioelectronic Gel Brings Living Tissue and Technology Closer Than Ever” »

Our ability to see begins with the light-sensitive photoreceptor cells in our eyes. A specific region of the retina, called the fovea, is responsible for sharp vision. Here, color-sensitive cone photoreceptors enable us to detect even the smallest details. The density of these cells varies from person to person.

Additionally, when we fixate on an object, our eyes make subtle, continuous movements, which also differ between individuals.

Researchers from the University Hospital Bonn (UKB) and the University of Bonn have now investigated how sharp vision is linked to these tiny eye movements and the mosaic of cones. Using high-resolution imaging and micro-psychophysics, they demonstrated that eye movements are finely tuned to provide optimal sampling by the cones. The results of the study have now been published in the journal eLife.

Boston Children’s Hospital and Harvard Medical School researchers have discovered a neuroimmune communication pathway that may drive endometriosis-associated pain and lesion growth.

Endometriosis is a debilitating inflammatory disease affecting up to 15% of women and is characterized by the growth of endometrial-like tissue outside the uterus. Treatments can currently only target symptoms, with over-the-counter pain medicines and hormonal birth control, or in some cases, surgery.

Endometriosis occurs when cell tissues normally found within the uterus lining take root in areas outside the uterus. This tissue is hormonally sensitive and can become inflamed, especially during menstrual cycles, and can cause severe cramping, pain, and other symptoms depending on the area affected.

An international team of researchers has provided a genetic diagnosis for 30 individuals whose condition was undiagnosed for years despite extensive clinical or genetic testing. The study, conducted by researchers at Baylor College of Medicine, National University of Singapore and collaborating institutions worldwide, was published in Genetics in Medicine.

“The story of our findings began with one patient I saw in the clinic presenting an uncommon combination of problems,” said first and co-corresponding author Dr. Daniel Calame, instructor of pediatric neurology and developmental neurosciences at Baylor.

“The patient had severe developmental conditions, epilepsy and complete insensitivity to pain, which was very atypical. The condition had remained undiagnosed despite numerous tests conducted by geneticists and neurologists.”

It’s common knowledge that our brains—and, specifically, our brain cells—store memories. But a team of scientists has discovered that cells from other parts of the body also perform a memory function, opening new pathways for understanding how memory works and creating the potential to enhance learning and to treat memory-related afflictions.

“Learning and memory are generally associated with brains and brain cells alone, but our study shows that other cells in the body can learn and form memories, too,” explains New York University’s Nikolay V. Kukushkin, the lead author of the study, which appears in the journal Nature Communications.

The research sought to better understand if non-brain cells help with memory by borrowing from a long-established neurological property—the massed-spaced effect—which shows that we tend to retain information better when studied in spaced intervals rather than in a single, intensive session—better known as cramming for a test.

Stem cells grown in microgravity aboard the International Space Station (ISS) have unique qualities that could one day help accelerate new biotherapies and heal complex disease, two Mayo Clinic researchers say. The research analysis by Fay Abdul Ghani and Abba Zubair, M.D., Ph.D., published in NPJ Microgravity, finds microgravity can strengthen the regenerative potential of cells. Dr. Zubair is a laboratory medicine expert and medical director for the Center for Regenerative Biotherapeutics at Mayo Clinic in Florida. Abdul Ghani is a Mayo Clinic research technologist. Microgravity is weightlessness or near-zero gravity.

Studying stem cells in space has uncovered cell mechanisms that would otherwise be undetected or unknown within the presence of normal gravity. That discovery indicates a broader scientific value to this research, including potential clinical applications.

Scientists raise the alarm following updated research ethics guidelines on heritable human genome editing.